Research progress of new technological therapies for Crohn's disease fistula
10.3760/cma.j.cn101480-20240119-00014
- VernacularTitle:克罗恩病肛瘘的新技术疗法研究进展
- Author:
Taiyin WANG
1
;
Xueliang SUN
;
Zhaozheng ZHANG
;
Jun DU
;
Li ZHANG
;
Yujing SUN
;
Ke WEN
Author Information
1. 南京中医药大学，南京 210023
- Publication Type:Journal Article
- Keywords:
Crohn's disease;
Fistula;
New technology therapies;
Platelet-rich plasma;
Haematopoietic stem-cell transplantation;
Mesenchymal stem cells;
Hyperbaric oxyge
- From:
Chinese Journal of Inflammatory Bowel Diseases
2024;08(6):462-466
- CountryChina
- Language:Chinese
-
Abstract:
Perianal lesions are characteristic manifestations of Crohn's disease (CD) at the same time often herald the progression of the disease. CD fistula is one of the most common lesions, and the commonly used medications and biologics are unable to cure CD fistula. In recent years, new technology therapies have been widely used by clinicians to treat CD fistula, including platelet-rich plasma, mesenchymal stem cells, haematopoietic stem-cell transplantation and hyperbaric oxygen therapy. This article provides an overview of the progress of these non-pharmacological therapies.
